Banefelt, J.
Åkesson, K.E.
Spångéus, A.
Ljunggren, O.
Karlsson, L.
Ström, O.
Ortsäter, G.
Libanati, C.
Toth, E.
Funding for this research was provided by:
UCB Pharma (N/A)
Article History
Received: 18 September 2018
Accepted: 10 January 2019
First Online: 24 January 2019
Compliance with ethical standards
:
: The study has been approved by the Regional Ethical Review Board in Stockholm and performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments. For this type of study, individual formal consent was not required.
: JB, LK, OS, and GO are employed by Quantify Research, and Quantify Research was funded by UCB Pharma to conduct this study.KEA has received lecture fees from Merck, UCB Pharma, Eli Lilly, Amgen, and Novartis.AS has received lecture fees from Amgen and Eli Lilly.OL has received lecture fees from Eli Lilly and Amgen.CL and ET are employed by, and own stocks in, UCB Pharma.